Wellington Management Group LLP Apellis Pharmaceuticals, Inc. Transaction History
Wellington Management Group LLP
- $557 Billion
- Q3 2024
A detailed history of Wellington Management Group LLP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 15,566,969 shares of APLS stock, worth $519 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
15,566,969
Previous 16,388,697
5.01%
Holding current value
$519 Million
Previous $629 Million
28.59%
% of portfolio
0.08%
Previous 0.11%
Shares
20 transactions
Others Institutions Holding APLS
# of Institutions
308Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$396 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$370 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$327 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$193 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.4MShares$147 Million4.68% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.66B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...